Overview

Double-blind Trial of Mannitol Cream to Block the Effect of Capsaicin Cream

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
Capsaicin is a TRPV1 (transient receptor potential vanilloid 1) agonist, causing pain upon application. The investigators wish to determine whether mannitol blocks the effect of capsaicin application. As both cream bases are identical and mannitol addition is the only difference between the creams, if the mannitol cream is more effective in blocking the effect of capsaicin on the TRPV1 (transient receptor potential vanilloid 1) receptor, the investigators will have established that mannitol down-regulates or blocks the TRPV1 (transient receptor potential vanilloid 1) receptor.
Phase:
N/A
Details
Lead Sponsor:
University of British Columbia
Treatments:
Capsaicin
Mannitol